OSR HEALTH, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- OSR HEALTH, INC. payments for repurchase of common stock for the quarter ending 2024-12-31 was $19.19M, a 46.70% decline year-over-year.
- OSR HEALTH, INC. payments for repurchase of common stock for the quarter ending 2024-09-30 was $0.00.
- OSR HEALTH, INC. payments for repurchase of common stock for the quarter ending 2023-12-31 was $36.00M.
- OSR HEALTH, INC. payments for repurchase of common stock for the quarter ending 2023-09-30 was $0.00.
- OSR HEALTH, INC. payments for repurchase of common stock for fiscal 2024 was $36.23M, a 0.66% increase from fiscal 2023.
- OSR HEALTH, INC. payments for repurchase of common stock for fiscal 2023 was $36.00M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2024-12-31 | $19.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-22 | $36.23M 10-K · filed 2025-04-22 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | |
| 2023-12-31 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-22 | $36.00M 10-K · filed 2025-04-22 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |